Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Safety of Yttrium-90 Ibritumomab Tiuxetan Radioimmunotherapy for Relapsed Low-Grade, Follicular, or Transformed Non-Hodgkin’s Lymphoma

PaperCitations, authors & open-access status

Safety of Yttrium-90 Ibritumomab Tiuxetan Radioimmunotherapy for Relapsed Low-Grade, Follicular, or Transformed Non-Hodgkin’s Lymphoma is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 291 citations, 2003 year and closed oa status.

291
Citations
2003
Year
closed
OA Status

Related on ScholarIQ

John Lister
Author
Journal of Clinical Oncology
Journal
Lymphoma Diagnosis and Treatment
Topic
Lymphoma Diagnosis and Treatment
Topic
Radiopharmaceutical Chemistry and Applications
Topic
Monoclonal and Polyclonal Antibodies Research
Topic
470M+ articles · free account